SEA-CD70
A Phase 1 Study of SEA-CD70 in Myeloid Malignancies
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1
- Enrollment
- 140 patients (estimated)
- Sponsors
- Seagen Inc.
- Tags
- Monoclonal Antibody
- Trial Type
- Treatment
- Last Update
- 1 week ago
- SparkCures ID
- 1990
- NCT Identifier
- NCT04227847
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.